The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJDS.L Regulatory News (JDS)

  • There is currently no data for JDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

9 Apr 2020 10:21

RNS Number : 3649J
Mandarin Oriental International Ltd
09 April 2020
 

The following announcement has been issued to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

9th April 2020 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2020.

 

The Group's performance was severely impacted by the COVID-19 pandemic, resulting in an unaudited underlying loss of some US$40 million in the first quarter. A majority of the Group's hotels are now effectively closed and, while most hotels in Asia remain open, they are experiencing single digit percentage occupancy levels.

 

The Group has taken a number of actions to manage costs and preserve cash. These include the suspension of non-essential expenses and capital expenditure, significantly reducing payroll costs through unpaid leave, furloughing, substantial voluntary salary reductions at all levels and participation in government support measures wherever possible. The payroll measures have been taken proportionate to the seniority and means of colleagues. The Directors would like to express their deep gratitude for the continuing dedication and resolve of colleagues during these difficult times.

 

It is too early to forecast the duration of the impact of COVID-19 on the business but, as a result of the substantial reduction in revenue and management fees from the Group's hotels, the underlying loss in the second quarter is expected to be larger than in the first quarter.

 

In light of the exceptional circumstances, the Directors have withdrawn their recommendation of a final dividend in respect of the 2019 financial year and the relevant resolution seeking approval for the payment of the dividend will no longer be put to shareholders at the Company's AGM on 6th May 2020.

 

The Group's balance sheet and liquidity position both remain strong and will enable it to sustain the current low levels of business activity for an extended period of time. At 31st March 2020, net debt was US$363 million compared to net debt of US$300 million at the end of 2019. Gearing was 6% of adjusted shareholders' funds. During the quarter, the Group invested US$19 million in the restoration of Mandarin Oriental Ritz, Madrid.

 

At 31st March 2020, in addition to US$229 million of cash reserves, the Group also had US$207 million in available debt facilities that are committed for four years. The Group's facilities are not subject to any cash flow covenants.

 

While the Group's operations are currently being dramatically impacted by events associated with the COVID-19 pandemic, Mandarin Oriental remains a powerful brand that is well positioned to benefit over the long-term, when demand for luxury travel returns.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a standard listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley (852) 2895 9288

Craig Beattie (852) 2895 9288

Brunswick Group Limited

David Ashton (852) 3512 5063

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DOCKKLBBBZLFBBV
Date   Source Headline
8th Nov 20169:19 amRNSJC&C 2016 Third Quarter Financial Statements
31st Oct 201610:05 amRNSTotal Voting Rights
31st Oct 20169:54 amRNSPT Astra - 2016 Third Quarter Financial Statements
27th Oct 201610:20 amRNSNine Months 2016 Results of PT Hero
14th Oct 201610:54 amRNSShares Purchase
13th Oct 201611:44 amRNSShares Purchase
12th Oct 20161:05 pmRNSDirector/PDMR Shareholding
12th Oct 201612:29 pmRNSTransaction in Own Shares
6th Oct 201610:24 amRNSAdditional Listing
30th Sep 201611:14 amRNSDirector Declaration
28th Sep 201610:24 amRNSDividend
26th Sep 201610:11 amRNSDividend
1st Sep 201610:37 amRNSDirector Declaration
31st Aug 201611:27 amRNSTotal Voting Rights
31st Aug 201610:09 amRNSCirc re. Scrip Dividend Scheme
22nd Aug 201610:25 amRNSDirector Declaration
10th Aug 201612:46 pmRNSDairy Farm Completes Fur Inv In Yonghui Superstore
5th Aug 201611:11 amRNSTransaction in Own Shares
4th Aug 201611:22 amRNSTransaction in Own Shares
3rd Aug 201610:10 amRNSDirector Declaration
1st Aug 201610:54 amRNSAstra, JC&C 2016 HY Results Ann. - Correction
1st Aug 201610:52 amRNSDirector Declaration
29th Jul 201610:49 amRNSJC&C - 2016 Half Year Financial Statements
29th Jul 201610:48 amRNSHalf Yearly Results - 6 Months Ended 30 June 2016
29th Jul 201610:48 amRNSHalf Yearly Results - 6 Months Ended 30 June 2016
28th Jul 201610:56 amRNSPT Astra - 2016 First Half Financial Statements
28th Jul 201610:09 amRNSHalf Yearly Results - 6 Months Ended 30 June 2016
28th Jul 201610:08 amRNSHalf Yearly Results - 6 Months ended 30 June 2016
27th Jul 201610:25 amRNSFirst Half 2016 Results of PT Hero
30th Jun 201610:32 amRNSTotal Voting Rights
30th Jun 201610:26 amRNSNotice of 2016 Half-Yearly Results
27th Jun 201611:49 amRNSTransaction in Own Shares
24th Jun 201612:12 pmRNSTransaction in Own Shares
22nd Jun 201611:02 amRNSTransaction in Own Shares
21st Jun 201611:19 amRNSTransaction in Own Shares
20th Jun 201611:22 amRNSTransaction in Own Shares
17th Jun 201611:15 amRNSTransaction in Own Shares
16th Jun 201611:42 amRNSTransaction in Own Shares
15th Jun 201610:51 amRNSTransaction in Own Shares
14th Jun 201611:19 amRNSTransaction in Own Shares
13th Jun 201611:16 amRNSTransaction in Own Shares
13th Jun 201610:11 amRNSDirectorate
10th Jun 201610:42 amRNSTransaction in Own Shares
8th Jun 201611:30 amRNSTransaction in Own Shares
7th Jun 201611:31 amRNSTransaction in Own Shares
6th Jun 201612:25 pmRNSTransaction in Own Shares
3rd Jun 201610:43 amRNSTransaction in Own Shares
3rd Jun 201610:42 amRNSDirector/PDMR Shareholding
31st May 201611:05 amRNSTotal Voting Rights
31st May 20167:21 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.